1
|
Teng L, Zu Q, Li G, Yu T, Job KM, Yang X, Di L, Sherwin CM, Enioutina EY. Herbal medicines: challenges in the modern world. Part 3. China and Japan. Expert Rev Clin Pharmacol 2016; 9:1225-33. [PMID: 27232545 DOI: 10.1080/17512433.2016.1195263] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
INTRODUCTION Medicinal plants, and formulations prepared from them, have been used in China and Japan for thousands of years. Nowadays, ancient formulations of Traditional Chinese and Kampo (Japanese) Medicines coexist with Western herbal medicines (HMs) and complement each other. HMs are used for the treatment of mild and chronic diseases, as an adjunct therapy, to improve wellbeing and delay aging, or as healthy (functional) foods. AREAS COVERED This article, a third part in a series of reviews, is focusing on history, use and regulation of the traditional and modern HMs in Japan and China. Materials available from legislative and governmental websites, PubMed and news media were used. Expert commentary: HMs are heavily regulated in both countries, often in a similar manner as conventional pharmaceutical drugs. The majority of herbal formulations are sold as over-the-counter medications supplied with leaflets describing indications and appropriate dosages for patients of different ages. Medical practitioners prescribe herbal formulations that are tailored to the needs of particular patients. Both countries had problems with adverse drug reactions and toxicity of single herbs and herbal formulations that have been investigated by authorities, and some drugs have been removed from the market.
Collapse
Affiliation(s)
- Lida Teng
- a Department of Drug Policy & Management, Graduate School of Pharmaceutical Sciences , The University of Tokyo , Tokyo , Japan
| | - Qiang Zu
- b School of Pharmacy , Nanjing University of Chinese Medicine , Nanjing , China.,c Jiangsu Engineering Research Center for Efficient Delivery System of Traditional Chinese Medicine , Nanjing , China.,d Nanjing Engineering Research Center for Industrialization Traditional Chinese Medicine Pellets , Nanjing , China
| | - Gangzhou Li
- e Division of Clinical Pharmacology, the Department of Pediatrics , University of Utah School of Medicine , Salt Lake City , UT , USA
| | - Tian Yu
- e Division of Clinical Pharmacology, the Department of Pediatrics , University of Utah School of Medicine , Salt Lake City , UT , USA
| | - Kathleen M Job
- e Division of Clinical Pharmacology, the Department of Pediatrics , University of Utah School of Medicine , Salt Lake City , UT , USA
| | - Xiaoyan Yang
- f Division of Pharmaceutical Sciences, School of Pharmacy , University of Missouri-Kansas City , Kansas City , MI , USA
| | - Liuqing Di
- b School of Pharmacy , Nanjing University of Chinese Medicine , Nanjing , China.,c Jiangsu Engineering Research Center for Efficient Delivery System of Traditional Chinese Medicine , Nanjing , China.,d Nanjing Engineering Research Center for Industrialization Traditional Chinese Medicine Pellets , Nanjing , China
| | - Catherine Mt Sherwin
- e Division of Clinical Pharmacology, the Department of Pediatrics , University of Utah School of Medicine , Salt Lake City , UT , USA.,g Department of Pharmacology and Toxicology , University of Utah , Salt Lake City , UT , USA
| | - Elena Y Enioutina
- e Division of Clinical Pharmacology, the Department of Pediatrics , University of Utah School of Medicine , Salt Lake City , UT , USA.,h Division of Microbiology and Immunology, the Department of Pathology , University of Utah School of Medicine , Salt Lake City , UT , USA
| |
Collapse
|